Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients

Articolo
Data di Pubblicazione:
2013
Abstract:
Comment on A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. [Oncotarget. 2012]
Tipologia CRIS:
01.01 Articolo in rivista
Keywords:
targeted therapy; combination therapy; leukemia initiating cells; PI3K; Akt; mTOR; cell cycle; apoptosis; autophagy; translation
Elenco autori:
Autori di Ateneo:
Link alla scheda completa:
https://iris.cnr.it/handle/20.500.14243/270588
Pubblicato in:
CELL CYCLE (GEORGET. TEX.)
Journal